Advanced NMR of Wilmington, MA, and Medical Diagnostics of Burlington,MA, are ready to send their merger proposal to a shareholder voteafter the Securities and Exchange Commission declared effectivea registration statement containing the proposal. The
Advanced NMR of Wilmington, MA, and Medical Diagnostics of Burlington,MA, are ready to send their merger proposal to a shareholder voteafter the Securities and Exchange Commission declared effectivea registration statement containing the proposal. The companiesannounced the merger in May after a protracted battle betweenMDI and erstwhile suitor Raytel (SCAN 5/10/95). The shareholdervotes are scheduled for Aug. 31.
Advanced NMR also reported financial results last week thatshow revenues of $4.3 million for the second quarter (end-June),up 195% compared to $1.5 million in sales in the same period lastyear. Net income for the quarter was $393,000 compared to a netloss of $593,000 in the second quarter of 1995.
The company said the improving results were due to growingsales of its InstaScan echo-planar imaging package, as well asthe shipment of two 3-tesla MRI scanners.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.